Cardiovascular Benefits Certain GLP-1 therapies demonstrate cardiovascular risk reduction, making them attractive for high-risk diabetic patients
Conversely, M2 macrophages exert anti-ferroptotic effects via IL-10 secretion, which downregulates ACSL4 expression and enhances ferroportin (FPN)-mediated iron export, as recently demonstrated in Cell Death Differ (2024)
- Vi nhng c a hay d ng v ph n c thai hoc ang cho con b cn tham kho kin chuyn gia y t trc khi s dng
In preclinical models, chronic GLP-1 administration improves depression-like behaviors even in lean animals, an effect not mediated by weight loss
Weekly administration on the same day helps maintain stable therapeutic levels and reinforces the habit of regular dosing
Late-onset ornithine carbamoyltransferase deficiency accompanying acute pancreatitis and hyperammonemia